The Food and Drug Administration announced on January 29 that it is revising the Paxlovid Emergency Use Authorization (EUA) Letter of Authorization to state that EUA-labeled Paxlovid distributed by the U.S. government will remain authorized only through March 8, 2024. FDA is working with Pfizer, the manufacturer of Paxlovid to ensure that the federal inventory of the drug is the correctly labeled product.

EUA-labeled Paxlovid with an expiration date earlier than February 29 can be returned by emailing PaxlovidEUAreturns@inmar.com or calling 877-740-6148.